Martin Makary, President Donald Trump’s nominee to run the U.S. FDA, on Thursday promised to convene the agency’s vaccine advisory committee, but did not commit to rescheduling a canceled meeting to discuss the composition of the next seasonal flu vaccine. Makary, appearing in front of the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing, said he was not involved in last week’s decision to cancel the flu vaccine meeting, but committed to receiving regular outside views if confirmed.
About the Author
